Your browser doesn't support javascript.
loading
CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry.
Solly, Françoise; Angelot, Fanny; Garand, Richard; Ferrand, Christophe; Seillès, Estelle; Schillinger, Françoise; Decobecq, Agnès; Billot, Maryse; Larosa, Fabrice; Plouvier, Emmanuel; Deconinck, Eric; Legrand, Faezeh; Saas, Philippe; Rohrlich, Pierre-Simon; Garnache-Ottou, Francine.
Affiliation
  • Solly F; Etablissement Français du sang Bourgogne franche Comté, Laboratoire d'hématologie-immunologie-biologie moléculaire, Besançon, France.
Cytometry A ; 81(1): 17-24, 2012 Jan.
Article in En | MEDLINE | ID: mdl-22052678
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / Biomarkers / Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Neoplasm, Residual / Neuropilin-1 / Flow Cytometry Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Cytometry A Year: 2012 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / Biomarkers / Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Neoplasm, Residual / Neuropilin-1 / Flow Cytometry Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Cytometry A Year: 2012 Type: Article Affiliation country: France